• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,106.85 787.30
( 1.07%)
Global Indices
Nasdaq
46,525.67 -61.07
(-0.13%)
Dow Jones
6,603.69 7.37
(0.11%)
Hang Seng
53,576.26 452.77
(0.85%)
Nikkei 225
10,436.29 71.50
(0.69%)
Forex
USD-INR
93.02 -0.15
(-0.16%)
EUR-INR
107.32 -0.65
(-0.60%)
GBP-INR
123.03 -0.78
(-0.63%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

Aarey Drugs & Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524412
INE198H01019
51.1335451
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AAREYDRUGS
44.69
153.31
EPS(TTM)
Face Value()
Div & Yield %
1.21
10
0
 

ERIS Lifesciences board approves acquisition of balance 30% stake in Swiss Parenterals
Nov 24,2025
The board of ERIS Lifesciences at its meeting held on 24 November 2025 has approved the acquisition of balance 30% of the total share capital of Swiss Parenterals, a subsidiary of the Company.

Further, the board has approved the issuance of up to 23,06,372 equity shares of the Company on preferential basis to discharge the consideration for acquisition of 30% stake in Swiss Parenterals.